Trial intelligence / Profile preview

Volume Loading vs Non-loading in CABG Induction

NCT05462847Completed

Sponsor
Kasr Al Ainy Hospital
Start
May 2021
Primary completion
May 2022
Modality
Intravenous Solution
Countries
1
01

Overview

Randomised, single-blind trial of ringer's acetate in hypotension (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Incidence of post-induction hypotension at 15 minutes. Started May 2021; status: completed.

02

Drugs

ringer's acetate
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT05462847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05462847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call